[1]
Ardérius, M. et al. 2016. Liraglutide: Evaluation of Clinical Benefit in a Portuguese Population with Diabetes Difficult to Control. Internal Medicine. 23, 4 (Dec. 2016), 16–21. DOI:https://doi.org/10.24950/rspmi.836.